« Can’t smell that foul odor? You may be developing dementia. | Main | Pfizer whistleblower crucified on CafePharma message board. »

August 14, 2007

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00d834519bc269e200e54ecadbd08833

Listed below are links to weblogs that reference FDA approved drug makes you hypersexual and a compulsive gambler! :

Comments

Mirapex taker

Oh brother. Where do I start.
I'm on Mirapex and before it took Requip.
Mirapex by my own and other patient's accounts is a bit more pronounced in effect due to increased Dopamine at the D4 receptor, or so my neurologist says.
Mirapex gives me random, rock-hard, 'afraid to get up from your desk like in 7th grade' erections throughout the day. I'm 36. It sucks. I get maybe 20 of these at work in 8 hours. Did I say rock hard? I mean hard as diamonds. Titanium. Wait it out and if the boss calls you in, say you have a leg cramp. This gets REALLY old REALLY fast.
Libido is somewhat increased under both drugs, yes, but it's different... in that it can strike suddenly. The article makes it sound like you become more horny. You don't. You can become more horny in a minute's notice totally out of the blue and you'll feel compulsed to jump your partner with NO warning. Too much of that can be irritating.
The gambling thing didn't happen to me, fortunately.
Mirapex has also increased my appetite... at night I feel like I have been on a freaking hunger strike.
This pill is too random to market it usefully for any of these side effects.

Sunil S Chiplunkar

Let us see the positives first. We appreciate that drugs are getting well researched including the side effect profile and these are presented to the public and healthcare professionals. No drug is free of side effects. It is here where the healthcare professional or the doctor's role comes in helping manage side effects through drug selection for the patient, duration of therapy and dosage titration.

Next it is unfortunate to see that in a bid to have patent ensured markets a lot of natural bioactives obviously nonpatentable are not being researched adequately and commercialized with gusto. This is in fact becoming the Achilles heel of BIG PHARMA. Recent failures namely, torcetrapib, rofecoxib and rosiglitazone,the shortening new product pipeline, and ever increasing costs of new product development should awaken the ivory tower managers and researchers to look for solutions beyond the trodden path. One way out is researching and marketing of natural bioactives based on usefulness and clinical data. This is where clinical trial development will play a role in strengthening consumption and better the topline and bottomline of companies.

Nevada Drug Rehab

Attending a long term drug rehab center helps drug addicted individuals by removing them from their environment for a period of time and provides a therapeutic environment with fewer distractions. This gives the person a safe place that is far away from former drug connections and places they would use drugs. It is extremely difficult to help a person with a severe drug or alcohol addiction without removing him or her from their environment. Rehab centers and Drug treatment center in Nevada are appropriate for all the above circumstances.
http://www.drugrehabscenters.com/

charlie

Question can a patient alternate through the day requip and mirapex along with stalevo.

Air Yeezy

some aritcles are very good,you said the word about you wants.we should live in our right styles.many times we usually say that u like style,and Air Yeezy I think you will like,too.link my name now to know them.

nike air max

I was once asked.*_*

Nike Free Run

and objectives of enterprise advancement. Due to the fact the value

buy simvastatin

On August 4 GlaxoSmithKline was forced to update its package insert for Requip, a drug used to treat restless legs syndrome (RLS) or, jitters in the legs, which some claim isn’t a real disease. What is real, is that Requip...

escort ankara

thnk you for sahring

SAMSUN ESCORT

nice talk here hello all

The comments to this entry are closed.

 
© 2010 Brandweek. All rights reserved. Terms Of Use and Privacy Policy Additional Terms Of Use and Privacy Policy.